GoAI
Get started
Bon Natural Life Limited logo

Bon Natural Life Limited

BON

NASDAQBasic MaterialsChemicals - Specialty

Open in GoAI

Previous close

$1.14

−$0.01 · -0.87%

Aug 21, 4:00 PM ET

BON company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

25

Expensive

Momentum

28

Weakening

Sentiment

52

Mixed

Risk resilience

31

High Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Bon Natural Life Limited, accompanied by its various subsidiaries, focuses on the innovation, production, and worldwide distribution of active functional compounds sourced from natural plant extracts. Its operations span the People's Republic of China and international markets. The company's diverse product range includes components for personal care items, such as plant-derived aromatic compounds supplied to manufacturers of perfumes and fragrances. It also develops natural health products, featuring powdered beverages and biologically active food ingredients primarily intended for use as food additives, as well as a variety of nutritional supplements. These offerings are predominantly utilized by industrial clients in the functional food, personal care, cosmetic, and pharmaceutical sectors. Founded in 2006, Bon Natural Life Limited's main office is located in Grand Cayman, Cayman Islands.

Industry
Chemicals - Specialty
Sector
Basic Materials
Headquarters
CN
CEO
Yongwei Hu
Listed since
Jun 24, 2021
Employees
96

Market position

Day range

Current $1.14

52-week range

Current $1.14

Open
$1.1334
Previous close
$1.15
Volume
3.86K
0.28× average
Average volume
13.84K
Average daily volume
Market cap
6.94M USD
Beta
-0.26
Market reference 1
50-day average
$1.1724
-2.77% below average
200-day average
$1.4474
-21.24% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
11.43M USD
P/E (TTM)
-4.96×
P/B (TTM)
0.05×
P/S (TTM)
0.37×
EV / EBITDA
-197.65×
Earnings yield
-37.13%
Free cash flow yield
-78.74%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
20.77%
Operating margin
-8.69%
Net margin
-10.68%
Return on equity
-3.47%
Return on assets
-2.34%
Return on invested capital
-2.31%

Financial health

Debt / equity
0.21×
Current ratio
1.74×
Altman Z-score
1.18
Piotroski F-score
1 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends36%19%2%-15%Gross margin, FY2021: 27.90%Gross margin, FY2022: 31.51%Gross margin, FY2023: 29.94%Gross margin, FY2024: 29.82%Gross margin, FY2025: 20.77%Operating margin, FY2021: 21.18%Operating margin, FY2022: 26.44%Operating margin, FY2023: 20.05%Operating margin, FY2024: 7.86%Operating margin, FY2025: -8.69%Net margin, FY2021: 18.01%Net margin, FY2022: 20.86%Net margin, FY2023: 15.57%Net margin, FY2024: 1.67%Net margin, FY2025: -10.68%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 27.90%. Gross margin FY2022 31.51%. Gross margin FY2023 29.94%. Gross margin FY2024 29.82%. Gross margin FY2025 20.77%. Operating margin FY2021 21.18%. Operating margin FY2022 26.44%. Operating margin FY2023 20.05%. Operating margin FY2024 7.86%. Operating margin FY2025 -8.69%. Net margin FY2021 18.01%. Net margin FY2022 20.86%. Net margin FY2023 15.57%. Net margin FY2024 1.67%. Net margin FY2025 -10.68%.

Income trends

Revenue

18.67M USD-21.70%

Operating income

−1.62M USD−3.5M USD

Net income

−1.99M USD−2.39M USD
Income trends across reported periods33.1M USD20.34M USD7.58M USD−5.19M USDRevenue, FY2021: 25.49M USDRevenue, FY2022: 29.91M USDRevenue, FY2023: 29.52M USDRevenue, FY2024: 23.84M USDRevenue, FY2025: 18.67M USDOperating income, FY2021: 5.4M USDOperating income, FY2022: 7.91M USDOperating income, FY2023: 5.92M USDOperating income, FY2024: 1.87M USDOperating income, FY2025: −1.62M USDNet income, FY2021: 4.59M USDNet income, FY2022: 6.24M USDNet income, FY2023: 4.6M USDNet income, FY2024: 398.17K USDNet income, FY2025: −1.99M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 25.49M USD. Revenue FY2022 29.91M USD. Revenue FY2023 29.52M USD. Revenue FY2024 23.84M USD. Revenue FY2025 18.67M USD. Operating income FY2021 5.4M USD. Operating income FY2022 7.91M USD. Operating income FY2023 5.92M USD. Operating income FY2024 1.87M USD. Operating income FY2025 −1.62M USD. Net income FY2021 4.59M USD. Net income FY2022 6.24M USD. Net income FY2023 4.6M USD. Net income FY2024 398.17K USD. Net income FY2025 −1.99M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue18.67M USD23.84M USD29.52M USD29.91M USD25.49M USD
Cost of goods sold14.79M USD16.73M USD20.68M USD20.48M USD18.38M USD
Gross profit3.88M USD7.11M USD8.84M USD9.42M USD7.11M USD
Research and development754.19K USD1.62M USD298.47K USD424.56K USD249.05K USD
Selling, general, and administrative4.75M USD3.62M USD2.61M USD2.4M USD1.46M USD
Operating expenses5.5M USD5.24M USD2.9M USD1.52M USD1.71M USD
Interest income867 USD393 USD9.42K USD1.39K USD3.21K USD
Interest expense366.18K USD303.26K USD238.22K USD446.88K USD417.27K USD
Depreciation and amortization1.29M USD1.28M USD1.18M USD366.61K USD286.69K USD
Operating income−1.62M USD1.87M USD5.92M USD7.91M USD5.4M USD
Net income−1.99M USD398.17K USD4.6M USD6.24M USD4.59M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
33%
2 beats, 4 misses, 0 met estimates
Average EPS surprise
-34.25%
6 comparable reports
Latest EPS result
-0.79

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates89.1656.9624.75-7.45Q3 '22BeatQ1 '23BeatQ3 '23MissQ1 '24MissQ3 '24MissQ1 '25MissQ3 '25No estimateQ1 '26No estimate
Q3 2022, reported Aug 1, 2022: actual 0.75, estimate 0.725, surprise +3.45%, Beat. Q1 2023, reported Feb 10, 2023: actual 1.1, estimate 0.8, surprise +37.50%, Beat. Q3 2023, reported Sep 11, 2023: actual 0.6, estimate 0.8, surprise -25.00%, Miss. Q1 2024, reported Feb 9, 2024: actual 2.64, estimate 80, surprise -96.70%, Miss. Q3 2024, reported Sep 9, 2024: actual 0.6, estimate 0.8, surprise -25.00%, Miss. Q1 2025, reported Jan 28, 2025: actual 0.23, estimate 82.5, surprise -99.72%, Miss. Q3 2025, reported Aug 19, 2025: actual 0.56, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Jan 23, 2026: actual -0.79, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates26.07M19.63M13.2M6.76MQ3 '22MissQ1 '23MissQ3 '23MissQ1 '24MissQ3 '24MissQ1 '25MissQ3 '25MissQ1 '26Met
Q3 2022, reported Aug 1, 2022: actual 13.69M USD, estimate 15.83M USD, surprise -13.53%, Miss. Q1 2023, reported Feb 10, 2023: actual 16.22M USD, estimate 16.49M USD, surprise -1.64%, Miss. Q3 2023, reported Sep 11, 2023: actual 14.15M USD, estimate 17.75M USD, surprise -20.28%, Miss. Q1 2024, reported Feb 9, 2024: actual 15.37M USD, estimate 19.88M USD, surprise -22.67%, Miss. Q3 2024, reported Sep 9, 2024: actual 14.15M USD, estimate 17.75M USD, surprise -20.28%, Miss. Q1 2025, reported Jan 28, 2025: actual 13.66M USD, estimate 24.73M USD, surprise -44.76%, Miss. Q3 2025, reported Aug 19, 2025: actual 7.95M USD, estimate 8.13M USD, surprise -2.17%, Miss. Q1 2026, reported Jan 23, 2026: actual 10.72M USD, estimate 10.72M USD, surprise 0.00%, Met estimate.

BON news

Corporate actions

Corporate action history

Stock split

Effective May 19, 2025

1:25

Stock split

Effective Apr 11, 2024

1:10

BON peers

Linde plc logo

LIN

Linde plc

$487.57

+1.30%

Steel Dynamics, Inc. logo

STLD

Steel Dynamics, Inc.

$228.68

+4.42%

Royal Gold, Inc. logo

RGLD

Royal Gold, Inc.

$259.01

+2.64%

Solstice Advanced Materials Inc. logo

SOLS

Solstice Advanced Materials Inc.

$56.16

-0.81%

SSR Mining Inc. logo

SSRM

SSR Mining Inc.

$37.77

+2.55%

Aura Minerals logo

AUGO

Aura Minerals

$87.26

+0.66%

Continue in GoAI

Research BON

research.disclaimer